Terms: = Sarcomas AND ERCC4, XPF, 2072, ENSG00000175595, Q92889 AND Prognosis
3 results:
1. Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma.
Wang MJ; Zhu Y; Guo XJ; Tian ZZ
Genet Mol Res; 2015 Sep; 14(3):11652-7. PubMed ID: 26436406
[TBL] [Abstract] [Full Text] [Related]
2. [Expressions of ERCC2 and ercc4 genes in osteosarcoma and peripheral blood lymphocytes and their clinical significance].
Li X; Guo W; Shen DH; Yang RL; Liu J; Zhao H
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 39(5):467-71. PubMed ID: 17940561
[TBL] [Abstract] [Full Text] [Related]
3. [Expression of genes of potential importance in the response to chemotherapy in osteosarcoma patients].
Nathrath M; Kremer M; Letzel H; Remberger K; Höfler H; Ulle T
Klin Padiatr; 2002; 214(4):230-5. PubMed ID: 12165907
[TBL] [Abstract] [Full Text] [Related]
